iSpecimen Inc. (ISPC) stock
ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 17, 2026Score 7/3045% below fair value
$0.53−0.06 (-10.57%)
Close on Nov 18, 2026Market cap $1.34MP/E –Yield –
iSpecimen free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
iSpecimen's free cash flow for the twelve months ending Dec 31, 2025 was -$4.24M. For fiscal 2025 it was -$4.24M. The highest annual figure on record is -$288.81K in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.24M | – |
| FY2024 | Dec 31, 2024 | -$8.30M | – |
| FY2023 | Dec 31, 2023 | -$5.83M | – |
| FY2022 | Dec 31, 2022 | -$6.03M | – |
| FY2021 | Dec 31, 2021 | -$10.67M | – |
| FY2020 | Dec 31, 2020 | -$288.81K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$916.92K | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.04M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.58M | -1137.4% |
| Q3 FY2024 | Sep 30, 2024 | -$1.09M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.54M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.08M | – |
| Q4 FY2023 | Dec 31, 2023 | $345.14K | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.64M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.70M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.83M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.32M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.08M | – |
| Q4 FY2020 | Dec 31, 2020 | -$24.07K | – |
| Q3 FY2020 | Sep 30, 2020 | -$319.41K | – |
See a number that looks wrong?